Canada’s telecom sector has been under pressure, but is the operating environment beginning to improve? TD Cowen's Vince ...

TD Cowen analyst William Katz maintained a Hold rating on Artisan Partners (APAM – Research Report) today and set a price target of $46.00. The ...

TD Cowen has upgraded CRISPR Therapeutics (CRSP) to hold from sell, stating it now sees less downside to the stock. Read more ...

In a report released today, Daniel Bergman from TD Cowen maintained a Buy rating on Primerica (PRI – Research Report), with a price target of ...

China-based GDS Holdings (GDS) is surging 6% after investment bank TD Cowen raised its price target on the shares. The ...

TD Cowen had upgraded Merck in early 2024 based on confidence in Keytruda and Gardasil’s performance, a lack of binary risks, and an attractive valuation. However, setbacks in Gardasil’s China sales ...

Metagenomi is a precision genetic medicines company committed to developing curative therapeutics for patients using its ...

DeepSeek has quickly gained attention in AI with its R1 model, which delivers high performance at a lower cost.

News of a significant price-target boost from an analyst tracking GDS Holdings ( GDS 7.20%) was the main catalyst behind the ...

CRISPR Therapeutics (NASDAQ:CRSP) received an upgrade in its stock rating by analysts at TD Cowen, changing from Sell to Hold, while maintaining a price target of $35.00. The revision in the rating ...